Magnetic Stimulation Therapy for Treating Vascular Depression (rtms)
Vascular Depression and Magnetic Stimulation Therapy
研究概览
地位
详细说明
Vascular depression is a condition that typically affects the elderly and is associated with small vascular lesions. It is more resistant to treatment and has a poorer outcome than nonvascular depression. By altering excitability in the cortical area of the brain, rTMS may be an effective treatment neuropsychiatric conditions, particularly depression.
Participants in this study will be randomly assigned to 15 treatments of either rTMS or sham rTMS for 3 weeks. Following treatment, participants will receive citalopram for 9 weeks. Response rates to treatment; relapse rates; the size, number, and location of the vascular lesions; and the amount of regional brain atrophy will be measured. Improvements in activities of daily living, quality of life, and cognitive function will also be also measured.
研究类型
注册 (预期的)
阶段
- 第三阶段
联系人和位置
学习地点
-
-
Iowa
-
Iowa City、Iowa、美国、52242-1087
- University of Iowa Health Care
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
描述
Inclusion Criteria:
- DSM-IV diagnosis of unipolar major or minor depressive disorder
- Hamilton Depression Rating Scale score of at least 18
- Depression that is associated with cerebrovascular disease
- Failed at least 1 treatment for vascular depression
学习计划
研究是如何设计的?
设计细节
- 主要用途:治疗
- 分配:随机化
- 介入模型:并行分配
- 屏蔽:三倍
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的:1
Participants will receive treatment with repetitive transcranial magnetic stimulation and citalopram.
|
Participants will receive 15 treatments of rTMS over 3 weeks.
After completing treatment with rTMS or sham rTMS, participants will take citalopram for 9 weeks.
|
|
有源比较器:2
Participants will receive treatment with sham repetitive transcranial magnetic stimulation and citalopram.
|
After completing treatment with rTMS or sham rTMS, participants will take citalopram for 9 weeks.
Participants will receive 15 treatments of sham rTMS over 3 weeks.
|
研究衡量的是什么?
主要结果指标
结果测量 |
大体时间 |
|---|---|
|
Response rates to treatment; relapse rates; the size, number, and location of the vascular lesions; and the amount of regional brain atrophy
大体时间:Measured at Week 12
|
Measured at Week 12
|
次要结果测量
结果测量 |
大体时间 |
|---|---|
|
Improvements in activities of daily living, quality of life, and cognitive function
大体时间:Measured at Week 12
|
Measured at Week 12
|
合作者和调查者
研究记录日期
研究主要日期
学习开始
初级完成 (实际的)
研究完成 (实际的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (估计)
研究记录更新
最后更新发布 (估计)
上次提交的符合 QC 标准的更新
最后验证
更多信息
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.